NPPA Issues Demand Notice to AstraZeneca over Pricing of Betaloc-50 Tablets
AstraZeneca Pharma India Limited has received a demand notice from the National Pharmaceutical Pricing Authority (NPPA) regarding alleged overcharging for its pharmaceutical product, Betaloc-50. The company confirmed that it is currently reviewing the notice and will take appropriate steps in accordance with applicable law.The NPPA issued the demand notice following an investigation into the pricing of Betaloc-50 (Metoprolol 50 mg tablets) under the Drugs (Prices Control) Order, 2013 (DPCO, 2013). The company received the notification on July 27, 2026.The NPPA has alleged that AstraZeneca Pharma India Ltd. sold or marketed Betaloc-50 at a Maximum Retail...